Youqiang Fang, Ph.D?

?

Titles

Professor of Surgery

Chief Physician

Master's Supervisor

Editorial Board of Chinese Journal of Endourology

Member of the Youth Standing Committee of Anti-cancer Association in Guangdong province

Committee members of Translational Medicine Association in Guangdong Urological and Reproductive Association

?

Research Interests

Basic and clinical study on tumor in urinary and reproductive system, including

l?The mechanism of new type molecular targeted drugs in prostate cancer treatment

l?Early diagnosis of prostate cancer

l?Multimodality therapy of prostate cancer

His early work focused on the basic and clinical study on prostate cancer. After study in McGill University, he paid most of his attention in the research of Combi-targeting molecule on the treatment of hormone-refractory prostate cancer. He has taken himself in this research for almost 9 years, and has gotten some important breakthrough.

?

Education and Experience

Training

l?Medical school of Sun Yat-Sen University (1998)

l?MD, the Third Affiliated hospital of Sun Yat-sen University(2003)

l?PhD, McGill University(2007)

Residency

l?the Third Affiliated hospital of Sun Yat-sen University(2008)

Certifications

l?Attending Doctor of urinary surgery(2010)

l?Associate Professor of urinary surgery(2012)

l?Master's Supervisor(2013)

l?Professor of urinary surgery(2018）

?

Honors and Awards

Publications

1.Fang Y, Wu J, Li T, et al. Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer. American journal of cancer research. 2015;5(8):2387-2395.

2.Fang YQ, Wu JY, Li TC, Liu W, Gao L, Luo Y. Nanoparticle mediated chemotherapy of hormone refractory prostate cancer with a novel combi-molecule. American journal of translational research. 2015;7(8):1440-1449.

3.Gao L, Fang YQ, Zhang TY, et al. Acidic extracellular microenvironment promotes the invasion and cathepsin B secretion of PC-3 cells. International journal of clinical and experimental medicine. 2015;8(5):7367-7373.

4.Gao L, Fang YQ, Zhang TY, et al. GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression. International journal of clinical and experimental medicine. 2014;7(9):2984-2991.

5.Li T, Fang Y, Wu J, Zhou X. A novel ureter dilatation method for replacing hydromantic perfusion pump during ureteroscopic lithotripsy in patients with ureteral calculi and ibroepithelial polyps. International journal of clinical and experimental medicine. 2014;7(3):616-621.

?

Contact

Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University,

600W Tianhe Road, Guangzhou 510630, China.

Tel. +86 20 85252052;

Fax: +86 20 85252678.